I-Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate CAS 74892-82-3 Argatroban Intermediate High Purity
Ubonelelo loMvelisi kwiArgatroban eNxulumeneyo naMaphakathi:
I-Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate CAS 74892-82-3
N-Nitro-1,2,3,4-tetradehydro Argatroban Ethyl Ester CAS 74874-09-2
I-3-Methyl-8-Quinolinesulphonyl Chloride CAS 74863-82-4
Argatroban Monohydrate CAS 141396-28-3
Argatroban Anhydrous CAS 74863-84-6
Igama leMchiza | I-Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate |
Izithethantonye | I-Ethyl (2R,4R)-4-Methylpipecolate;(2R,4R)-4-Methyl-2-Piperidinecarboxylate;(2R,4R)-Ethyl 4-Methylpiperidine-2-Carboxylate;I-Ethyl-(2R,4R)-4-Methylpiperidine-2-Carboxylate |
Inombolo yeCAS | 74892-82-3 |
Inombolo yeCAT | RF-PI267 |
Ubume beStokhwe | Kwi-Stock, iMveliso yoMveliso ukuya kwiiToni |
Ifomula yeemolekyuli | C9H17NO2 |
Ubunzima beMolekyuli | 171.24 |
Imeko yokuthumela ngenqanawa | Ithunyelwe Ngaphantsi Kweqondo Lobushushu Le-Ambient |
Uphawu | Ruifu Chemical |
Into | Iinkcukacha |
Imbonakalo | Kucacile ukuKhanya ulwelo olutyheli |
Diastereoisomer | ≤1.0% |
Ubunyulu / Indlela yokuHlalutya | ≥98.0% (GC) |
Iintsimbi ezinzima | ≤20ppm |
Umgangatho woVavanyo | Umgangatho woShishino |
Ukusetyenziswa | Argatroban Intermediate (CAS 74863-84-6) |
Iphakheji: Ibhotile, umgqomo, 25kg / umphanda, okanye ngokwemfuno umthengi.
Imeko yoGcino:Gcina kwizikhongozeli ezivaliweyo kwindawo epholileyo neyomileyo;Khusela ekukhanyeni, ukufuma kunye nokuhlaselwa zizinambuzane.
I-Shanghai Ruifu Chemical Co., Ltd. ngumenzi ohamba phambili kunye nomthengisi we-Ethyl (2R,4R) -4-Methyl-2-Piperidinecarboxylate (CAS: 74892-82-3) kunye nomgangatho ophezulu.I-Ethyl (2R,4R)-4-Methyl-2-Piperidinecarboxylate (CAS: 74892-82-3) yindawo ephakathi ngokuqhelekileyo kwi-synthesis ye-Argatroban Monohydrate (CAS 141396-28-3) okanye i-Argatroban (CAS 74863-84-6) ).
I-Argatroban Monohydrate yi-thrombin inhibitor ethile, eyi-non-heparin anticoagulant, inqanda ukubunjwa kwe-thrombi.I-Argatroban yi-anticoagulant eyi-molecule encinci ye-thrombin inhibitor.Kwi-2000, i-argatroban ilayisensi yi-Food and Drug Administration (FDA) ye-prophylaxis okanye unyango lwe-thrombosis kwizigulane ezine-heparin-induced thrombocytopenia (HIT).